Article
The race to patent bio-tests for schizophrenia and depression: some say this initiative is destined to fail.
Recent articles by Arline Kaplan and Hagop Asiskal, MD, highlight the race to patent bio-tests for schizophrenia and depression. Dr Max Fink continues the discussion in his commentary; he contends the DSM divisions serve patients and doctors poorly. Tell us what you think.